About
Robert Nelsen is a co-founder and Managing Director of ARCH Venture Partners, one of the best-known life-science and deep-tech venture firms. ARCH says he has helped create, source, finance, and develop more than 150 companies, with notable investments spanning Illumina, Vir Biotechnology, Prime Medicine, Sana Biotechnology, Maze Therapeutics, Seaport Therapeutics, Xaira Therapeutics, and UNITY Biotechnology. He is also a company builder and board-level operator across biotechnology, AI, genomics, neuropsychiatry, and advanced biomanufacturing.
Areas of interest
longevityaging biologybiotechlife sciencesgenomicsdiagnosticsimmunologysynthetic biologygene editingRNA therapeuticsAIgenerative AIdeep techde-extinctioncell therapycancerinfectious diseasesports technologywomen's health